Table 1.
Characteristics | Genotype 1 (N = 70) |
Genotype 2 (N = 33) |
Genotype 3 (N = 260) |
Other Genotypes (N = 6) * |
Mixed Genotypes (N = 31)† |
---|---|---|---|---|---|
Sex-No. (%) | |||||
Male | 47 (67.1) | 22 (66.7) | 185 (71.2) | 6 [100] | 20 (64.5) |
Female | 23 (32.9) | 11 (33.3) | 75 (28.8) | 0 [0] | 11 (35.5) |
Age range-years | |||||
Mean age (Y) | 25–70 | 21–68 | 18–55 | 20–57 | 21–60 |
± SD‡ | 50 ± 9.5 | 48 ± 9.0 | 45 ± 10.2 | 49 ± 9.8 | 46 ± 8.4 |
Ethnic group-No. (%) | |||||
Panjabi | 50 (71.4) | 21 (63.6) | 203 (78.1) | 4 (66.7) | 21 (67.7) |
Pashtoons | 15 (21.4) | 10 (30.3) | 41 (15.8) | 2 (33.3) | 10 (32.3) |
Balochi | 3 (4.2) | 1 (3.0) | 7 (2.7) | 0 | 0 |
Sindhi | 2 (2.9) | 1 (3.0) | 9 (3.4) | 0 | 0 |
Pre-treatment HCV RNA level | |||||
< 200,000 IU/mL | 22 (31.4%) | 11 (33.3) | 71 (27.3) | 1 (16.7) | 4 (12.9) |
> 200,000 IU/mL | 48 (68.6) | 22 (66.7) | 189 (72.7) | 5 (83.3) | 27 (87.1) |
Cirrhosis-No (%) | |||||
Present | 3 (4.3) | 2 (6.1) | 9 (3.5) | 0 [0] | 2 (6.5) |
Absent/unknown | 67 (95.7) | 31 (93.9) | 251 (96.5) | 6 [100] | 29 (93.5) |
*Of the patients with other genotypes, 4 had HCV genotype 4 and one each was with genotype 5a and 6a.
†Out of 31 patients with mixed genotypes, 13 were with genotypes 3a+3b; 4 with 2a+3b; 3 each with 2a+3a & 1a+1b, 2 each with 1a+3a & 3a+4; 1 each with 1a+3c, 1b+2a, 1c+3b & 1c+3c.
‡SD, standard deviation.